Welcome to your XPONENTIAL Exhibitor Console!
The Exhibitor Console is your XPONENTIAL hub for all the information you need to know – from deadlines to promotional items - in one convenient location.
| Important Dates and Information |
|
Virtual Platform Launch
Note: only registered attendees can access the virtual platform and virtual booth.
|
September 28, 2020
|
|
Virtual Platform Coffee Talk
-
Zoom Link
- Meeting ID: 865 9877 2303
- Passcode: 447699
- Phone: +1 301 715 8592
|
October 1, 2020
1:00pm EST
|
|
XPONENTIAL 2021 Rebook
Rebook will take place during XPONENTIAL 2020. You will receive an email by Thursday, October 5 with your rebook time. This will be the time that you can log into the system and select your physical booth location for XPONENTIAL 2021 scheduled for Atlanta May 3-6.
|
October 7-8, 2020 |
Use our Promotional Toolkit to share your participation at XPONENTIAL and give your customers a discounted registration with code EXHOFFXPO20!
Profile
Joseph R. Scalea, MD (Joe) is a multi-organ transplant surgeon at the University of Maryland School of Medicine and the University of Maryland Medical Center in Baltimore. He attended medical school at the University of Maryland before entering a post-doctoral fellowship at Harvard University to study transplantation immunology. After completing formal transplant surgical training at the University of Wisconsin he was recruited to lead the pancreas and islet transplant program at the University of Maryland in Baltimore. Under Dr. Scalea’s leadership, the University of Maryland combined kidney-pancreas program grew to the become the largest in the United States as of 2018. Dr. Scalea is passionately interested in eliminating the ongoing organ shortage which has devastating effects on patients with organ failure. Accordingly, he leads a translational immunology laboratory focused on identifying mechanisms to maximize organ efficiency through antirejection medicine avoidance, thus allowing patients “one transplant for life.” Further, he has most recently become interested in reducing the frictions in the organ delivery supply chain with the greater goal of maximizing the number of available organs. To this end, his pioneering work with unmanned aircraft systems (UAS) demonstrates that innovated organ transportation could reduce cost, reduce time, and improve organ quality. Dr. Scalea and his research team were recently recognized for performing the first-ever shipment of an organ by UAS as well as for the first-ever transplant of a human organ (kidney) transported by UAS. While saving one life through surgical transplantation is gratifying, saving thousands through research and innovation is to what Dr. Scalea has devoted his career.
Sessions